Bright Minds Biosciences
DRUG
8 hedge funds and large institutions have $326K invested in Bright Minds Biosciences in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
27% more capital invested
Capital invested by funds: $257K → $326K (+$69.6K)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.18% less ownership
Funds ownership: 0.84% → 0.66% (-0.18%)
11% less funds holding
Funds holding: 9 → 8 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$37.2K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$9.4K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$188 |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$11 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SS
Simplicity Solutions
Minneapolis,
Minnesota
|
-$20.3K |
| 2 |
QFA
Quattro Financial Advisors
The Woodlands,
Texas
|
-$9.31K |
| 3 |
Renaissance Technologies
New York
|
-$9.28K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$4.95K |
| 5 |
APC
Aspire Private Capital
Cornelius,
North Carolina
|
-$220 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AI
1
AdvisorShares Investments
Bethesda,
Maryland
| $294K | +$37.2K | +13,232 | +15% |
|
|
TSS
2
Two Sigma Securities
New York
| $9.53K | +$9.4K | +3,345 | New |
|
|
CCA
3
Checchi Capital Advisers
Beverly Hills,
California
| $8.06K | – | – | – |
|
4
BlackRock
New York
| $6.73K | – | – | – |
|
|
5
Renaissance Technologies
New York
| $6K | -$9.28K | -3,301 | -60% |
|
|
6
UBS Group
Zurich,
Switzerland
| $1.2K | -$4.95K | -1,760 | -81% |
|
|
7
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$188 | +67 | +16% |
|
|
SS
8
Simplicity Solutions
Minneapolis,
Minnesota
| – | -$20.3K | -9,241 | Closed |
|
|
QFA
9
Quattro Financial Advisors
The Woodlands,
Texas
| – | -$9.31K | -4,230 | Closed |
|
|
APC
10
Aspire Private Capital
Cornelius,
North Carolina
| – | -$220 | -100 | Closed |
|
|
11
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | +$11 | +4 | New |
|
DRUG Hedge Fund Activity: Q2 2023 in Review
8 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Bright Minds Biosciences (DRUG) for Q2 2023, worth a combined $326K — up 27% from $257K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of DRUG and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 2 added.
The largest buyer was AdvisorShares Investments, adding an estimated $37.2K. The largest seller was Simplicity Solutions, exiting entirely with an estimated $20.3K sold.
- 8 institutional investors held Bright Minds Biosciences (DRUG) as of Q2 2023, down from 9 in Q1 2023.
- Funds reported $326K of Bright Minds Biosciences stock for Q2 2023, up 27% quarter-over-quarter.
- 2 funds opened new Bright Minds Biosciences positions in Q2 2023 and 3 closed out, a net change of -1 holder.
- The largest Bright Minds Biosciences buyer in Q2 2023 was AdvisorShares Investments, an estimated $37.2K added.
- The largest Bright Minds Biosciences seller in Q2 2023 was Simplicity Solutions, an estimated $20.3K sold.
Based on aggregated 13F filings for Q2 2023.